Lisata Therapeutics Inc.

LSTA | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.56

-$0.14 (-8.24%)

At close: Sep 21, 2026, 4:00 PM ET

$1.58

+$0.02 (+1.12%)

Pre-market: Sep 22, 2026, 8:12 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-16.59M	-19.99M	-20.84M	-54.23M	-27.47M	-8.14M
Depreciation & Amortization	146K	174K	189K	69K	55K	63K
Stock-Based Compensation	1.23M	1.65M	2.04M	2.64M	2.01M	1.27M
Other Working Capital	882K	1.02M	-550K	-608K	-603K	522K
Other Non-Cash Items	552K	-325K	-957K	31.18M	2.51M	307K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.29M	-873K	-462K	-831K	647K	-2.32M
Operating Cash Flow	-15.95M	-19.36M	-20.03M	-21.17M	-22.25M	-8.82M
Capital Expenditures	-28K	n/a	n/a	-285K	-60K	-20K
Cash Acquisitions	n/a	-130K	n/a	-3.32M	54.84K	7.26K
Purchase of Investments	-9.18M	-55.69M	-98.48M	-89.69M	-179.78M	-34.8M
Sales Maturities Of Investments	24.29M	69.05M	108.58M	122.2M	124.94M	27.54M
Other Investing Acitivies	n/a	n/a	n/a	n/a	-54.84K	-7.26K
Investing Cash Flow	15.09M	13.23M	10.1M	28.91M	-54.9M	-7.28M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-253K	-274K	64K	-267K	-224K	-148K
Financial Cash Flow	599K	-206K	385K	-224K	85.28M	18.58M
Net Cash Flow	-253K	-6.38M	-9.56M	7.51M	8.14M	2.48M
Free Cash Flow	-15.98M	-19.36M	-20.03M	-21.46M	-22.31M	-8.84M
Adj. Free Cash Flow	-17.2M	-21.01M	-22.07M	-24.09M	-24.31M	-10.11M
Maintenance CapEx	-28K	n/a	n/a	-285K	-60K	-20K
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-15.98M	-19.36M	-20.03M	-21.46M	-22.31M	-8.84M